CaixaBank, S.A.’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
– Sell
-360
Closed -$21.3K – 344
2016
Q4
$21.3K Buy
+360
New +$22.2K ﹤0.01% 186

Other funds holding XBI

CaixaBank, S.A.'s XBI Position: Q1 2017 in Review

CaixaBank, S.A. sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2017, closing a stake of 360 shares — an estimated $21.3K sold.

CaixaBank, S.A. first reported a position in XBI in Q4 2016 and held it in 1 quarter. The position peaked at $21.3K in Q4 2016. 292 funds tracked by Wall St. Rank hold XBI as of Q1 2017.

  • CaixaBank, S.A. reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2017 after selling out during the quarter.
  • CaixaBank, S.A. sold 360 State Street SPDR S&P Biotech ETF shares in Q1 2017, an estimated $21.3K.
  • CaixaBank, S.A. first reported a position in State Street SPDR S&P Biotech ETF in Q4 2016 and held it in 1 quarter.
  • CaixaBank, S.A.'s State Street SPDR S&P Biotech ETF position peaked at $21.3K in Q4 2016.
  • 292 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2017.

Based on CaixaBank, S.A.'s 13F filing for Q1 2017, filed 16 Nov 2026.